Eliot Richard Forster, MBA, Ph.D.

Eliot Richard Forster is Chairman of the Board at Granite Bio.  Dr. Forster is Chief Executive Officer of Levicept, a privately-held, UK- based biotechnology company. He is also Non-Executive Director of Immatics (NASDAQ:IMTX) and Non-Executive Chairman of Protalix Biotherapeutics (AMEX:PLX). In addition, he is the Non-Executive Chairman of Ochre Bio, a UK-based private biotechnology company and Non-Executive Chairman of Tessellate BIO, a Netherlands-based private biotechnology company. Previously, he was CEO of F-Star Therapeutics Ltd. (NASDAQ:FSTX) until its sale to invoX and CEO of Immunocure, Creabilis and Solace Pharmaceuticals. Earlier in his career, he held positions at Pfizer and GSK. Dr. Forster holds a B.Sc. (Hons) and a Ph.D. from the University of Liverpool and an MBA from the Henley Management College. He is an Honorary Visiting Professor at the University of Liverpool and at the University of Pavia.